HCV gene | Core | Core | E2 | E2 | E2 | NS2 | NS2 | NS2 | NS2 | NS2 | NS2 | NS3 | NS5A | NS5A | NS5A | NS5B |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nucleotide number and type | ||||||||||||||||
J6/JFH1 position | 572 | 621 | 1641 | 1679 | 2528 | 2952 | 2955 | 2964 | 2965 | 2978 | 3051 | 4306 | 7069 | 7164 | 7389 | 7697 |
H77 abs. ref. (AF009606) | 573 | 622 | 1642 | 1680 | 2517 | 2941 | 2944 | 2953 | 2954 | 2967 | 3040 | 4295 | 7070 | 7165 | 7390 | 7632 |
Nucleotide of J6/JFH1 | A | C | A | T | T | G | G | A | T | G | A | C | G | T | A | A |
J6/JFH1 Infected human liver chimeric mouse samples | ||||||||||||||||
B139—serum (ex vivo) | • | T/C | • | • | • | • | • | A/g | A/t | • | • | • | • | T/A | • | • |
B139—1st passage in cell culture | • | T/c | • | • | • | • | • | • | A | • | • | • | • | A/t | • | • |
B156—serum (ex vivo) | • | T/C | • | • | • | • | • | A/g | A/t | • | • | • | • | T/a | • | • |
B156—1st passage in cell culture | • | T/c | • | • | • | • | • | • | A | • | • | • | • | A | • | • |
J6/JFH1ΔHVR1 Infected human liver chimeric mouse samples | ||||||||||||||||
K826R—plasma (ex vivo) | • | • | • | • | G/t | T | • | • | • | • | • | • | • | • | • | • |
K826R—1st passage in cell culture | • | • | • | • | G | T | • | • | • | • | • | • | • | • | • | • |
K890R—plasma (ex vivo) | • | • | G/a | G | • | • | A | • | • | • | G | • | • | • | G/A | G/A |
K890R—1st passage in cell culture | • | • | G | G | • | • | A | • | • | • | G | • | • | • | • | • |
B150R—plasma (ex vivo) | A/c | • | • | • | • | • | • | A/g | • | C/g | • | • | • | • | • | • |
B150R—1st passage in cell culture | C/A | • | • | • | • | • | • | • | • | C/g | • | • | • | • | • | • |
J6/JFH1A876P Infected human liver chimeric mouse samples | ||||||||||||||||
K1219RL—1st passage in cell culture | • | • | • | • | • | • | • | • | • | C | • | • | • | • | • | • |
K1216L—1st passage in cell culture | • | • | • | • | • | • | • | • | • | C | • | • | C/G | • | • | • |
K1207—1st passage in cell culture | • | • | • | • | • | • | • | • | • | C | • | G/c | • | • | • | • |
J6/JFH1ΔHVR1/A876P Infected human liver chimeric mouse samples | ||||||||||||||||
B413L—1st passage in cell culture | A/g | • | • | • | • | • | • | • | • | C | • | • | • | • | • | • |
B413RL—1st passage in cell culture | • | • | • | • | G | • | • | • | • | C | • | • | • | • | • | • |
K1207R—1st passage in cell culture | A/g | • | • | T/g | T/g | • | • | • | • | C | • | • | • | • | • | • |
K1207L—1st passage in cell culture | • | • | • | • | G/t | • | • | • | • | C | • | • | • | • | • | • |
Amino acid number and type | ||||||||||||||||
J6/JFH1 position | 78 | 94 | 434 | 447 | 730 | 871 | 872 | 875 | 875 | 880 | 904 | 1322 | 2243 | 2275 | 2350 | 2453 |
H77 abs. ref. (AF009606) | 78 | 94 | 434 | 447* | 726* | 867 | 868 | 871 | 871 | 876 | 900 | 1318 | 2243 | 2275 | 2350 | 2431 |
Change relative to J6/JFH1 | K→Q/E | A→V | H→R | F→V | L→V | R→L | G→D | D→G | D→E | A→P | Y→C | C→W | Q→H | M→K | K→R | I→V |
The entire open reading frame of viruses was sequenced. The cell culture viruses were sequenced at peak of infection. Only nucleotide changes resulting in amino acid changes are shown. Capital letters indicate the presence of one determinate sequence peak. Two capital letters separated by a slash indicate the presence of a 50/50 quasispecies, whereas a capital letter separated by a slash from a lowercase letter indicates a quasispecies with a dominant versus a minor sequence. Light grey indicates mutation cluster between amino acid positions 867–876. Dark grey indicates mutation introduced to the virus genome by cloning.
*Mutations F447V and L726V were generated for J6/JFH1 and J6/JFH1ΔHVR1 recombinant viruses and were found to have minor in vitro adaptive fitness effects for the hypervariable region 1 (HVR1)-deleted variant, but not for J6/JFH1, and to have no effect on neutralisation susceptibility of J6/JFH1ΔHVR1 against H06 IgG.